论文部分内容阅读
随着急性心肌梗死(AMI)溶栓,PTCA及合理的药物治疗,越来越多的心血管病患者存活下来,因而慢性充血性心衰(CHF)的患者日益增多,成为心血管病防治的跨世纪挑战,尽管不断出现CHF新的治疗手段,CHF的死亡率仍居高不下,顽固性心力衰竭又称“难治性心力衰竭”是指尽管经ACEI、利尿剂、洋地黄等系统治疗,但严重的心力衰竭仍不见好转的状况,自2002-11-2005-5月,我科对13例难治性心衰患者采取中西结合治疗,取得满意疗效,现报告如下:
With acute myocardial infarction (AMI) thrombolysis, PTCA and rational drug treatment, more and more patients with cardiovascular disease survive, so that patients with chronic congestive heart failure (CHF) are increasing, becoming a cardiovascular disease prevention Cross-century challenges, despite the continued emergence of new CHF treatment, CHF mortality remains high, refractory heart failure, also known as “refractory heart failure” refers to despite the ACEI, diuretics, digitalis and other systemic treatment, However, serious heart failure is still not improved condition, since 2002 - 11 - 2005-5 months, our department of 13 cases of refractory heart failure patients with Chinese and Western treatment, and achieved satisfactory results, are as follows: